abstract |
The present invention relates to compositions and methods for the treatment of diseases characterized by overexpression of LIV-1. More specifically, the composition comprises the DNA or amino acid sequence of the LIV-1 antibody against LIV-1, and the method is directed to the treatment of a mammal susceptible to or diagnosed with a cancer in which LIV-1 is overexpressed. It's a way. |